Incyte to Present at Upcoming Investor Conferences
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/16/2026
- Wall St futures pause after two-day rally as investors await data, earnings
- TSMC Q2 profit jumps 77% to record, far surpasses expectations
- U.S. headline producer inflation posts first one-month decrease since August 2025
- Oil eases as traders weigh US-Iran conflict risks
- PayPal rallies 20% on report Stripe, Advent made $53 billion bid
Incyte (INCY) PT Raised to $67 at RBC Capital
August 15, 2024 6:14 AM EDTRBC Capital analyst Brian Abrahams raised the price target on Incyte (NASDAQ: INCY) to $67.00 (from $66.00) while maintaining a Sector Perform rating.
The analyst comments "Although axatilimabs approval came earlier than expected, we believe it was largely already baked into valuation, launch is delayed... More
